[VANILLIC ACID AS THE END PRODUCT OF ADRENALIN AND NORADRENALIN DECOMPOSITION. III. SYNTHESIS OF VANILLIC ACID FROM D,L-3-METHOXY-4-HYDROXY MANDELIC ACID USING RAT AND HUMAN LIVER HOMOGENATES].

W. Dirscherl,B. Brisse

Acta Endocrinologica

Abstract:

What problem does this paper attempt to address?

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

Jingyu Wang,Yuan Li,Meiman Ding,Honghe Zhang,Xiaoming Xu,Jinlong Tang

DOI: https://doi.org/10.3892/ijo.2016.3811

2016-01-01

International Journal of Oncology

Abstract:miRNAs (microRNAs) have been validated to play fateful roles in the occurrence and development of cancers by post-transcriptionally targeting 3′-untranslated regions of the downstream gene mRNAs to repress mRNA expression. Mounting investigations forcefully document that not only does miR-22 biologically impinge on the processes of senescence, energy supply, angiogenesis, EMT (epithelial-mesenchymal transition), proliferation, migration, invasion, metastasis and apoptosis, but also it genetically or epigenetically exerts dual (inhibitory/promoting cancer) effects in various cancers via CNAs (copy number alterations), SNPs (single nucleotide polymorphisms), methylation, acetylation and even more momentously hydroxymethylation. Additionally, miR-22 expression may fluctuate with cancer progression in the body fluids of cancer patients and miR-22 could amplify its inhibitory or promoting effects through partaking in positive or negative feedback loops and interplaying with many other related miRNAs in the cascade of events, making it possible for miR-22 to be a promising and complementary or even independent cancer biomarker in some cancers and engendering profound influences on the early diagnosis, therapeutics, supervising curative effects and prognosis.
microRNA 21 and long non-coding RNAs interplays underlie cancer pathophysiology: A narrative review

Roberta Giordo,Fatemeh Abdullah M. Ahmadi,Nedal Al Husaini,Noora Rashid A.M. Al-Nuaimi,Salma M.S. Ahmad,Gianfranco Pintus,Hatem Zayed

DOI: https://doi.org/10.1016/j.ncrna.2024.03.013

2024-04-03

Non-coding RNA Research

Abstract:Non-coding RNAs (ncRNAs) are a diverse group of functional RNA molecules that lack the ability to code for proteins. Despite missing this traditional role, ncRNAs have emerged as crucial regulators of various biological processes and have been implicated in the development and progression of many diseases, including cancer. MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are two prominent classes of ncRNAs that have emerged as key players in cancer pathophysiology. In particular, miR-21 has been reported to exhibit oncogenic roles in various forms of human cancer, including prostate, breast, lung, and colorectal cancer. In this context, miR-21 overexpression is closely associated with tumor proliferation, growth, invasion, angiogenesis, and chemoresistance, whereas miR-21 inactivation is linked to the regression of most tumor-related processes. Accordingly, miR-21 is a crucial modulator of various canonical oncogenic pathways such as PTEN/PI3K/Akt, Wnt/β-catenin, STAT, p53, MMP2, and MMP9. Moreover, interplays between lncRNA and miRNA further complicate the regulatory mechanisms underlying tumor development and progression. In this regard, several lncRNAs have been found to interact with miR-21 and, by functioning as competitive endogenous RNAs (ceRNAs) or miRNA sponges, can modulate cancer tumorigenesis. This work presents and discusses recent findings highlighting the roles and pathophysiological implications of the miR-21-lncRNA regulatory axis in cancer occurrence, development, and progression. The data collected indicate that specific lncRNAs, such as MEG3, CASC2, and GAS5, are strongly associated with miR-21 in various types of cancer, including gastric, cervical, lung, and glioma. Indeed, these lncRNAs are well-known tumor suppressors and are commonly downregulated in different types of tumors. Conversely, by modulating various mechanisms and oncogenic signaling pathways, their overexpression has been linked with preventing tumor formation and development. This review highlights the significance of these regulatory pathways in cancer and their potential for use in cancer therapy as diagnostic and prognostic markers.

biochemistry & molecular biology
[Indirect lymphography with temporary occlusion of the blood capillaries].

P. Málek,J. Kolc

Acta Radiologica

Abstract:
Unravelling the Impact of miR-21 Overexpression on the MicroRNA Network and Cancer Pathways

Meredith Hill,Sarah Stapleton,Phuong Thao Nguyen,Dayna Sais,Fiona Deutsch,Valarie Gay,Deborah Marsh,Nham Tran

DOI: https://doi.org/10.1101/2024.05.10.593469

2024-05-14

Abstract:MicroRNAs (miRNA, miRs) are small noncoding RNAs that are ubiquitously expressed in all mammalian cells. Their primary function is the regulation of nascent RNA transcripts by direct binding to regions on the target. There is now exciting data to suggest that these miRNAs can bind to other miRNAs, and this may have a broader impact on gene regulation in disease states. The oncomiR, miR-21 is one of the highest-expressing miRNAs in cancer cells, and in this study, we characterise which miRNAs could be potential targets of miR-21. In cancer cells delivered with a miR-21 mimic, there was an observable shift of the miRNA milieu in these cells. We demonstrate that the miR-17-92a cluster, which harbours six miRNA members, maybe a target of miR-21 regulation. Additionally, the primary transcript of miR-17-92a was reduced in the presence of miR-21. This is one of the few examples that show the direct regulation of miRNA clusters by miR-21. In the broader context of gene regulation, the overexpression of miR-21 shifted the expression of more than 150 miRNAs. Mapping this impact, it was clear that the change in the miRNA milieu affected cancer pathways such as the MAPK signalling and FoxO pathways. This study adds to our limited understanding of miR:miR regulatory network and reinforces the concept that miRNAs can regulate each other, thereby influencing broader gene regulatory networks.

Cell Biology
Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.

Zhao-Xia Wang,Hai-Bo Bian,Ji-Rong Wang,Zhi-Xiang Cheng,Ke-Ming Wang,Wei De

DOI: https://doi.org/10.1002/jso.22008

2011-01-01

Journal of Surgical Oncology

Abstract:Background: Deregulation of microRNAs (miRNAs) plays important roles in tumor progression. The aim of this study was to investigate miR-21 expression in serum of non-small cell lung cancer (NSCLC) and its correlation with prognosis of NSCLC patients. Methods: Dysregulated miRNAs in NSCLC serum were identified by microarray. MiR-21 expression in NSCLC and control serum was detected by TaqMan RT-PCR assay. The correlation of serum miR-21 with clinicopathological factors of NSCLC patients was analyzed. Furthermore, the prognostic significance of serum miR-21 was analyzed by using Kaplan-Meier curves with log-rank tests and a Cox proportional hazard model. Results: The level of miR-21 expression was higher in NSCLC serum samples than in control serum samples (P < 0.01). High serum miR-21 was significantly correlated with tumor-node metastases stage and lymph node metastasis of NSCLC patients (P = 0.016 and 0.026, respectively). The 3-year actuarial overall survival rates in NSCLC patients with high serum miR-21 expression (39.8%) was significantly shorter than those with low serum miR-21 expression (58.2%; P < 0.001). Furthermore, univariate and multivariate analyses for overall survival showed that serum miR-21 expression was an independent prognostic factor for NSCLC patients (P = 0.015, RR = 2.01, 95% CI: 1.78-3.26). Conclusion: Serum miR-21 expression might be useful as a prognostic marker for NSCLC patients. J. Surg. Oncol. 2011;104:847-851. (C) 2011 Wiley Periodicals, Inc.
MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer

Yiying Wu,Yi Song,Yao Xiong,Xiaodong Wang,Ke Xu,Bin Han,Yang Bai,Li Li,Yuanyuan Zhang,Liming Zhou,Bin Han

DOI: https://doi.org/10.1159/000481648

2017-01-01

Cellular Physiology and Biochemistry

Abstract:Background/Aims: MicroRNA-21 (miR-21) has been demonstrated to play an important role in carcinogenesis; however, its mechanism of action in colorectal cancer (CRC) has not been fully elucidated. The aim of the present study was to explore the oncogenic function of miR-21 and its molecular mechanism in CRC. Methods: A total of 105 paired tumor and tumor-adjacent normal tissue specimens from CRC patients and two CRC cell lines (HCT-116 and SW480) were studied. The protein and mRNA expression levels of PTEN and miR-21 were examined using western blot analysis and real-time reverse transcription-PCR (qRT-PCR). Furthermore, we transfected CRC cells with different combinations of ectopic-expression vector or shRNA expression vector of miR-21 and phosphatase and tensin homolog (PTEN) to modulate the expression levels of miR-21 and PTEN respectively, and then analyzed the phenotypic alterations of CRC cells. Tumorigenesis was also evaluated by xenografting HCT-116 cells into nude mice. Results: In this study, we showed that miR-21 expression was significantly up-regulated in CRC compared to that in normal tissues. Patients with advanced Tumor-Node-Metastasis (TNM) stage, lymph node metastasis, local invasion and higher serum carcinoembryonic antigen (CEA) levels displayed significantly high expression of miR-21. The PTEN protein level in CRC tissues and cells was inversely correlated with miR-21 expression. Furthermore, the transfection of CRC cells with pre-miR-21 could inhibit apoptosis and promote cellular proliferation, invasion, cell cycle progression and growth of xenografts in nude mice, whereas the transfection of miR-21-specific shRNA resulted in the opposite phenomena. In addition, silencing or elevating PTEN protein could partially reverse the effect of miR-21-specific shRNA or pre-miR-21 on apoptosis, cell cycle distribution, and invasion of CRC cells. Moreover, over-expression or knockdown of miR-21 altered the protein expression of PTEN and phosphorylated Akt (p-AKT). Conclusion: miR-21 can modulate the malignant phenotypes such as proliferation, anti-apoptosis, cell cycle progression and invasion of CRC cells by down-regulating PTEN protein expression. The results of study might improve our understanding of the regulatory mechanism of miR-21 and provide useful targets and approaches for the clinical diagnosis and therapy of CRC.
The Multifaceted Role of miR-21 in Pancreatic Cancers

Clare Chen,Lusine Demirkhanyan,Christopher S. Gondi

DOI: https://doi.org/10.3390/cells13110948

IF: 6

2024-05-31

Cells

Abstract:With the lack of specific signs and symptoms, pancreatic ductal adenocarcinoma (PDAC) is often diagnosed at late metastatic stages, resulting in poor survival outcomes. Among various biomarkers, microRNA-21 (miR-21), a small non-coding RNA, is highly expressed in PDAC. By inhibiting regulatory proteins at the 3′ untranslated regions (UTR), miR-21 holds significant roles in PDAC cell proliferation, epithelial–mesenchymal transition, angiogenesis, as well as cancer invasion, metastasis, and resistance therapy. We conducted a systematic search across major databases for articles on miR-21 and pancreatic cancer mainly published within the last decade, focusing on their diagnostic, prognostic, therapeutic, and biological roles. This rigorous approach ensured a comprehensive review of miR-21's multifaceted role in pancreatic cancers. In this review, we explore the current understandings and future directions regarding the regulation, diagnostic, prognostic, and therapeutic potential of targeting miR-21 in PDAC. This exhaustive review discusses the involvement of miR-21 in proliferation, epithelial–mesenchymal transition (EMT), apoptosis modulation, angiogenesis, and its role in therapy resistance. Also discussed in the review is the interplay between various molecular pathways that contribute to tumor progression, with specific reference to pancreatic ductal adenocarcinoma.

cell biology
miR-21: a small multi-faceted RNA

Anna M Krichevsky,Galina Gabriely

DOI: https://doi.org/10.1111/j.1582-4934.2008.00556.x

Abstract:More than 1000 microRNAs (miRNAs) are expressed in human cells, some tissue or cell type specific, others considered as house-keeping molecules. Functions and direct mRNA targets for some miRNAs have been relatively well studied over the last years. Every miRNA potentially regulates the expression of numerous protein-coding genes (tens to hundreds), but it has become increasingly clear that not all miRNAs are equally important; diverse high-throughput screenings of various systems have identified a limited number of key functional miRNAs over and over again. Particular miRNAs emerge as principal regulators that control major cell functions in various physiological and pathophysiological settings. Since its identification 3 years ago as the miRNA most commonly and strongly up-regulated in human brain tumour glioblastoma [1], miR-21 has attracted the attention of researchers in various fields, such as development, oncology, stem cell biology and aging, becoming one of the most studied miRNAs, along with let-7, miR-17-92 cluster ('oncomir-1'), miR-155 and a few others. However, an miR-21 knockout mouse has not yet been generated, and the data about miR-21 functions in normal cells are still very limited. In this review, we summarise the current knowledge of miR-21 functions in human disease, with an emphasis on its regulation, oncogenic role, targets in human cancers, potential as a disease biomarker and novel therapeutic target in oncology.
Prospects for miR-21 as a Target in the Treatment of Lung Diseases

Yan Ding,Yapeng Hou,Yanhong Liu,Xiaoyong Xie,Yong Cui,Hongguang Nie

DOI: https://doi.org/10.2174/1381612826999200820160608

Abstract:MicroRNA (miRNA/miR) is a class of small evolutionarily conserved non-coding RNA, which can inhibit the target gene expression at the post-transcriptional level and serve as significant roles in cell differentiation, proliferation, migration and apoptosis. Of note, the aberrant miR-21 has been involved in the generation and development of multiple lung diseases, and identified as a candidate of biomarker, therapeutic target, or indicator of prognosis. MiR-21 relieves acute lung injury via depressing the PTEN/Foxo1-TLR4/NF-κB signaling cascade, whereas promotes lung cancer cell growth, metastasis, and chemo/radio-resistance by decreasing the expression of PTEN and PDCD4 and promoting the PI3K/AKT transduction. The purpose of this review is to elucidate the potential mechanisms of miR-21 associated lung diseases, with an emphasis on its dual regulating effects, which will trigger novel paradigms in molecular therapy.
MicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis

Wenjia Wang,Jinhui Li,Wei Zhu,Chen Gao,RuiJingfang Jiang,Wenxue Li,Qiansheng Hu,Bo Zhang

DOI: https://doi.org/10.1186/1471-2407-14-819

IF: 4.638

2014-01-01

BMC Cancer

Abstract:Background MicroRNA-21 (miR-21) has been suggested to play a significant role in the prognosis of carcinoma. The recognition of novel biomarkers for the prediction of cancer outcomes is urgently required. However, the potential prognostic value of miR-21 in various types of human malignancy remains controversial. The present meta-analysis summarises and analyses the associations between miR-21 status and overall survival (OS) in a variety of tumours. Methods Eligible published studies were identified by searching the PubMed and Chinese Biomedicine databases. The patients’ clinical characteristics and survival results were pooled, and a pooled hazard ratio (HR) with 95% confidence intervals (95% CI) was used to calculate the strength of this association. A random-effects model was adopted, and then, meta-regression and subgroup analyses were performed. In addition, an analysis of publication bias was also conducted. Results Twenty-seven eligible articles (including 31 studies) were identified that included survival data for 3273 patients. The pooled HR suggested that high miR-21 was clearly related to worse overall survival (HR = 2.27, 95% CI: 1.81-2.86), with a heterogeneity measure index of I 2 = 76.0%, p = 0.001, showing that miR-21 might be a considerable prognostic factor for poor survival in cancer patients. Conclusions MiR-21 might be a potentially useful biomarker for predicting cancer prognosis in future clinical applications.
Emerging role of microRNA-21 in colorectal cancer.

Zhao Jun,Xu Guifang,Zhang Yisheng,Zhao Guohai

DOI: https://doi.org/10.3233/CBM-150468

2015-01-01

Cancer Biomarkers

Abstract:Colorectal cancer (CRC) is one of the most common types of cancers worldwide. In spite of much progress in surgery, chemotherapy and molecular targeted therapy, the mortality rate has only decreased slightly over the past years. MicroRNAs are 18-25 nucleotide, noncoding RNA molecules that regulate the translation of many genes. Evidence suggests that miRNAs may play an important role in a variety of cellular biological processes, such as cell growth, differentiation, metabolism, invasion, angiogenesis. Recently, miR-21 is found to be aberrantly expressed in CRC and miR-21 has been recognized to perform significantly in CRC, where miR-21 can regulate several different target genes and pathways involving tumor proliferation, invasion and metastasis. In this study, we will focus on the critical role of miR-21 in CRC. Hopefully, the information obtained may lead to a better understanding of the pathogenesis and development of novel therapeutic strategies for this disease.
MicroRNA-21 in Gynecological cancers: From molecular pathogenesis to clinical significance

Ni-Jie Jiang,Ya-Nan Yin,Jiao Lin,Wen-Yuan Li,De-Rong Long,Ling Mei

DOI: https://doi.org/10.1016/j.prp.2023.154630

2023-06-23

Abstract:Ovarian, cervical, and endometrial cancers are the three most common gynecological cancer types (GCs). They hold a significant position as the leading causes of mortality among women with cancer-related death. However, GCs are often diagnosed late, severely limiting the efficacy of current treatment options. Thus, there is an urgent, unmet need for innovative experimentation to enhance the clinical treatment of GC patients. MicroRNAs (miRNAs) are a large and varied class of short noncoding RNAs (22 nucleotides in length) that have been shown to play essential roles in various biological processes involved in development. Recent research has shown that miR-211 influences tumorigenesis and cancer formation, adding to our knowledge of the miR-21 dysregulation in GCs. Furthermore, current research that sheds light on the crucial functions of miR-21 may provide supporting evidence for its potential prognostic, diagnostic, and therapeutic applications in the context of GCs. This review will thus focus on the most recent findings concerning miR-21 expression, miR-21 target genes, and the processes behind GCs. In addition, the latest findings that support miR-21's potential use as a non-invasive biomarker and therapeutic agent for detecting and treating cancer will be elucidated in this review. The roles played by various lncRNA/circRNA-miRNA-mRNA axis in GCs are also comprehensively summarized and described in this study, along with any possible implications for how these regulatory networks may contribute to the pathogenesis of GCs. Also, it is crucial to recognize the complexity of the processes involved in tumour therapeutic resistance as a significant obstacle in treating GCs. Furthermore, this review provides an overview of the current state of knowledge regarding the functional significance miR-21 in therapeutic resistance within the context of GCs.

pathology
Melatonin affects the expression of microRNA-21: A mini-review of current evidence

Mahdi Rafiyian,Farzaneh Gouyandeh,Maryam Saati,Amirhossein Davoodvandi,Sayyed Mehdi Rasooli Manesh,Reza Asemi,Mehran Sharifi,Zatollah Asemi

DOI: https://doi.org/10.1016/j.prp.2024.155160

IF: 3.309

2024-01-21

Pathology - Research and Practice

Abstract:Melatonin (MLT) is an endogenous hormone produced by pineal gland which possess promising anti-tumor effects. Anti-inflammatory and anti-oxidant properties of MLT, along with its immunomodulatory, proapoptotic, and anti-angiogenic properties, are often referred to the main mechanisms of its anti-tumor effects. Recent evidence has suggested that epigenetic alterations are also involved in the anti-tumor properties of MLT. Among these MLT-induced epigenetic alterations is modulation of the expression of several oncogenic and tumor suppressor microRNAs(miRNAs). MiRNAs are among the most promising and potential therapeutic and diagnostic tools in different diseases and enhanced the development of better therapeutic drugs. Suppression of oncomicroRNAs such as microRNA-21, -20a, and -27a as well as, up-regulation of microRNA-34 a/c are among the most important effects of MLT on microRNAs homeostasis. Recently, miR-21 has attracted the attention of scientists due to the its wide range of effects on different cancers and diseases. Regulation of this RNA may be a key to the development of better therapeutic targets. The present review will summarize the findings of in vitro and experimental studies of MLT-induced impacts on the expression of microRNAs which are involved in different models and numerous stages of tumor initiation, growth, metastasis, and chemo-resistance.

pathology
Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma

Guan-Li Huang,Xiao-Hua Zhang,Gui-Long Guo,Ka-Te Huang,Kai-Yan Yang,Xian Shen,Jie You,Xiao-Qu Hu,Zhang

DOI: https://doi.org/10.3892/or_00000270

2009-07-06

Oncology Reports

Abstract:Growing evidence suggests microRNAs (miRNAs) have an important role in tumorigenesis. MicroRNA-21 (miR-21) is up-regulated in many malignant tumors, including breast cancer. Its association with clinicopathologic features and expression of PTEN (phosphatase and tensin homolog deleted on chromosome 10), one of its target genes, in breast cancer has not been reported systematically. To further determine the potential involvement of miR-21 in breast cancer, we have evaluated the expression level of miR-21 by stem-loop real-time RT-PCR based on SYBR-Green I in human invasive ductal carcinoma of the breast, and we have correlated the results with clinicopathologic features and PTEN protein expression. Matched non-tumor and tumor tissues of 40 human invasive ductal carcinoma of the breast were analyzed for miR-21 expression by stem-loop real-time RT-PCR based on SYBR-Green I. Immunohistochemistry (IHC) was used to estimate PTEN expression in tumor tissue. The expression levels of miR-21 were correlated with PTEN and commonly used clinicopathologic features of breast cancer. The stem-loop real-time RT-PCR based on SYBR-Green I was sensitive and specific enough to detect miR-21. Expression levels of miR-21 were significantly higher in tumor tissues than the levels in matched non-tumor tissues (P=0.000). Expression of miR-21 was negatively correlated with expression of PTEN (P=0.013). Up-regulated miR-21 expression was associated with lymph node positivity (P=0.01), higher proliferation index (ki67>10%) (P=0.03) and advanced breast cancer TNM clinical stage (P=0.021). These findings suggest that PTEN is possibly one of the targets of miR-21 in breast cancer and high expression of mir-21 indicates a more aggressive phenotype.

oncology
Prognostic Value of Mir-21 in Various Cancers: an Updating Meta-Analysis

Xin Zhou,Xiaping Wang,Zebo Huang,Jian Wang,Wei Zhu,Yongqian Shu,Ping Liu

DOI: https://doi.org/10.1371/journal.pone.0102413

IF: 3.7

2014-01-01

PLoS ONE

Abstract:Background: Recently, more and more studies investigated the value of microRNA (miRNA) as a diagnostic or prognostic biomarker in various cancers. MiR-21 was found dysregulated in almost all types of cancers. While the prognostic role of miR-21 in many cancers has been studied, the results were not consistent.Methods: We performed a meta-analysis to investigate the correlation between miR-21 and survival of general cancers by calculating pooled hazard ratios (HR) and 95% confidence intervals (CI).Results: The pooled results of 63 published studies showed that elevated miR-21 was a predictor for poor survival of general carcinomas, with pooled HR of 1.91 (95% CI: 1.66-2.19) for OS, 1.42 (95% CI: 1.16-1.74) for DFS and 2.2 (95% CI: 1.64-2.96) for RFS/CSS. MiR-21 was also a prognostic biomarker in the patients who received adjuvant therapy, with pooled HR of 2.4 (95% CI: 1.18-4.9) for OS.Conclusions: Our results showed that miR-21 could act as a significant biomarker in the prognosis of various cancers. Further studies are warranted before the application of the useful biomarker in the clinical.
Evaluation of miR-21 Inhibition and its Impact on Cancer Susceptibility Candidate 2 Long Noncoding RNA in Colorectal Cancer Cell Line

Miganoosh Simonian,Mohammadreza Sharifi,Reza Nedaeinia,Meysam Mosallaie,Sharifeh Khosravi,Amir Avan,Majid Ghayour-Mobarhan,Hadi Bagheri,Rasoul Salehi

DOI: https://doi.org/10.4103/abr.abr_214_16

2018-01-01

Advanced Biomedical Research

Abstract:BACKGROUND: Both microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) have been shown to have a critical role in the regulation of cellular processes such as cell growth and apoptosis, as well as cancer progression and metastasis. lncRNAs are aberrantly expressed in many diseases including cancer. Although it is well known that miRNAs can target a large number of protein-coding genes, little is known whether miRNAs can also target lncRNAs. In the present study, we determine whether miR-21 can regulate lncRNA cancer susceptibility candidate 2 (CASC2) in colorectal cancer.MATERIALS AND METHODS: LS174T cells were transfected with locked nucleic acid (LNA)-anti-miR-21 and scrambled LNA for 24, 48 and 72 h. The expression of miR-21 and lncCASC2 was evaluated by quantitative reverse transcriptase polymerase chain reaction.RESULTS: However, contrary to what we expected and reported by others, lncCASC2 quantity was significantly reduced in LNA treated LS174T cells compared to the scrambled treated and normal untreated cells (<i>P</i> < 0.05).CONCLUSION: The interaction of miRNA and lncRNA are not as simple as suggested by other reports. Moreover, it could be complex molecular mechanisms underlying the communication of various noncoding RNA elements.
Role and mechanism of miR-211 in human cancer

Lingling Ye,Fen Wang,Jinyan Wang,Hao Wu,Hui Yang,Zhaohui Yang,Haiwei Huang

DOI: https://doi.org/10.7150/jca.71401

IF: 3.9

2022-01-01

Journal of Cancer

Abstract:MircoRNA (miRNA), which are a group of small, and highly conserved non-coding RNA consisting of 18-25 nucleotides, can modulate gene expression at post-transcriptional level, through complementary binding to the 3'-untranslated region (3'-UTR) of numerous target genes. Emerging evidence indicates that miRNAs play critical roles in tumorigenesis and progression of cancer. Among them, miR-211 has been extensively studied in multiple cancers. The expression of miR-211 significantly varies with cancer types and may be used as a potential prognostic marker for cancer. MiR-211 can regulate multiple biological processes in cancer, including proliferation, apoptosis, metastasis and drug resistance. Additionally, several factors may contribute to the dysregulation of miR-211 in cancer. Consequently, this review aims to discuss the novel findings that highlight latent value of miR-211 in the prognosis assessment and treatment of cancer.

oncology
MicroRNA-21's Role in PTEN Suppression and PI3K/AKT Activation: Implications for Cancer Biology

Himmat Singh Chawra,Mohit Agarwal,Anurag Mishra,Shailendra Singh Chandel,Ravindra Pal Singh,Gaurav Dubey,Neelima Kukreti,Mithilesh Singh

DOI: https://doi.org/10.1016/j.prp.2024.155091

IF: 3.309

2024-01-05

Pathology - Research and Practice

Abstract:MicroRNA-21 (miR-21) was recognized as a key figure in the intricate web of tumor biology, with a prominent role in regulating the PTEN tumor suppressor gene and the PI3K/AKT cascade. This review elucidates the multifaceted interactions between miR-21, PTEN, and the PI3K/AKT signaling, shedding light on their profound implications in cancer initiation, progression, and therapeutic strategies. The core of this review delves into the mechanical intricacies of miR-21-mediated PTEN suppression and its consequent impact on PI3K/AKT pathway activation. It explores how miR-21, as an oncogenic miRNA, targets PTEN directly or indirectly, resulting in uncontrolled activation of PI3K/AKT, fostering cancerous cell survival, proliferation, and evasion of apoptosis. Furthermore, the abstract emphasizes the clinical relevance of these molecular interactions, discussing their implications in various cancer types, prognostic significance, and potential as therapeutic targets. The review provides insights into ongoing research efforts to develop miR-21 inhibitors and strategies to restore PTEN function, offering new avenues for cancer treatment. This article illuminates the critical function of miR-21 in PTEN suppression and PI3K/AKT activation, offering profound insights into its implications for cancer biology and the potential for targeted interventions.

pathology
Therapeutic effect of microRNA-21 on differentially expressed hub genes in gastric cancer based on systems biology

Hesam Ghafouri Kalajahi,AmirHossein Yari,Mohammad Amini,Tunc Catal,Mahya Ahmadpour Youshanlui,Omid Pourbagherian,Cigdem Sezer Zhmurov,Ahad Mokhtarzadeh

DOI: https://doi.org/10.1038/s41598-023-49225-8

2023-12-11

Abstract:Gastric cancer (GC) is a leading cause of mortality for many people. Cancer's initiating factors are poorly understood. miR-21 has a crucial function in several malignancies, particularly GC. Furthermore, it has been shown that miR-21 is critical for the emergence and advancement of GC. This work intends to identify new genes which expression is associated with the activity of mir-21 in GC and to investigate the effect of downregulation of mir-21 on these genes and gastric tumorigenesis. We utilized the gene expression profiles of GCs from an Array database (GSE13911) from the Gene Expression Omnibus (GEO) dataset to find differentially expressed genes (DEGs) between control and gastric cancer groups. Using weighted gene correlation network analysis (WGCNA) in R, the Gene co-expression network was reconstructed. The microRNA-mRNA network was then reconstructed using the miRWalk database, and by investigating the microRNA-mRNA network, the genes that have an association with mir-21 were found. To implement the functional investigation, MKN and AGS cell lines were transfected with anti-miR-21 next. Subsequently, MTT proliferation was utilized to assess the cell's vitality. qRT-PCR was then used to evaluate the anticipated levels of gene expression in both GC cell lines. This study discovered and predicted CCL28, NR3C2, and SNYPO2 as the targets of miR-21 (GC), which are downregulated through gastric tumorigenesis, showing great potential as therapeutic and diagnostic targets. The suppression of miR-21 in gastric GC cells led to the inhibition of cell proliferation and decreased expression of CCL28, NR3C2, and SNYPO2 genes. This study established that miR-21, via downregulating these genes, contributes significantly to the development of GC. In addition, systems biology techniques identified CCL28, NR3C2, and SNYPO2 genes as possible GC surveillance and therapy components.
The clinical value of miRNA-21 in cervical cancer: A comprehensive investigation based on microarray datasets

Zhi-Min Deng,Gan-Hong Chen,Fang-Fang Dai,Shi-Yi Liu,Dong-Yong Yang,An-Yu Bao,Yan-Xiang Cheng

DOI: https://doi.org/10.1371/journal.pone.0267108

IF: 3.7

2022-04-29

PLoS ONE

Abstract:Previous work has demonstrated that the expression of microRNA-21 (miR-21) is implicated in cervical cancer (CC). However, little is known regarding its associations with clinical parameters. We first conducted a meta-analysis using data from Gene Expression Omnibus (GEO) microarrays and The Cancer Genome Atlas (TCGA). Then, enrichment analysis and hub gene screening were performed by bioinformatic methods. Finally, the role of the screened target genes in CC was explored. According to the meta-analysis, the expression of miR-21 in cancer tissues was higher than in adjacent nontumor tissues ( P < 0.05). In addition, 46 genes were predicted as potential targets of miR-21. After enrichment analyses, it was detected that these genes were enriched in various cancer pathways, including the phosphatidylinositol signaling system and mammalian target of rapamycin (mTOR) signaling pathway. In this study, bioinformatic tools and meta-analysis validated that miR-21 may function as a highly sensitive and specific marker for the diagnosis of CC, which may provide a novel approach to the diagnosis and treatment of CC.

multidisciplinary sciences

[VANILLIC ACID AS THE END PRODUCT OF ADRENALIN AND NORADRENALIN DECOMPOSITION. III. SYNTHESIS OF VANILLIC ACID FROM D,L-3-METHOXY-4-HYDROXY MANDELIC ACID USING RAT AND HUMAN LIVER HOMOGENATES].

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

microRNA 21 and long non-coding RNAs interplays underlie cancer pathophysiology: A narrative review

[Indirect lymphography with temporary occlusion of the blood capillaries].

Unravelling the Impact of miR-21 Overexpression on the MicroRNA Network and Cancer Pathways

Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer.

MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer

The Multifaceted Role of miR-21 in Pancreatic Cancers

miR-21: a small multi-faceted RNA

Prospects for miR-21 as a Target in the Treatment of Lung Diseases

MicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysis

Emerging role of microRNA-21 in colorectal cancer.

MicroRNA-21 in Gynecological cancers: From molecular pathogenesis to clinical significance

Melatonin affects the expression of microRNA-21: A mini-review of current evidence

Clinical significance of miR-21 expression in breast cancer: SYBR-Green I-based real-time RT-PCR study of invasive ductal carcinoma

Prognostic Value of Mir-21 in Various Cancers: an Updating Meta-Analysis

Evaluation of miR-21 Inhibition and its Impact on Cancer Susceptibility Candidate 2 Long Noncoding RNA in Colorectal Cancer Cell Line

Role and mechanism of miR-211 in human cancer

MicroRNA-21's Role in PTEN Suppression and PI3K/AKT Activation: Implications for Cancer Biology

Therapeutic effect of microRNA-21 on differentially expressed hub genes in gastric cancer based on systems biology

The clinical value of miRNA-21 in cervical cancer: A comprehensive investigation based on microarray datasets